Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Blood levels of dual-specificity phosphatase-1 independently predict risk for post-operative morbidities causing prolonged hospitalization after coronary artery bypass grafting.

Hägg S, Alserius T, Noori P, Ruusalepp A, Ivert T, Tegnér J, Björkegren J, Skogsberg J.

Int J Mol Med. 2011 Jun;27(6):851-7. doi: 10.3892/ijmm.2011.650. Epub 2011 Mar 17.

PMID:
21424112
3.

Pre-operative high sensitive C-reactive protein predicts cardiovascular events after coronary artery bypass grafting surgery: a prospective observational study.

Balciunas M, Bagdonaite L, Samalavicius R, Griskevicius L, Vuylsteke A.

Ann Card Anaesth. 2009 Jul-Dec;12(2):127-32. doi: 10.4103/0971-9784.53442.

4.

Assessment of changes in general health status using the short-form 36 questionnaire 1 year following coronary artery bypass grafting.

Lindsay GM, Hanlon P, Smith LN, Wheatley DJ.

Eur J Cardiothorac Surg. 2000 Nov;18(5):557-64.

PMID:
11053817
5.

Coronary atherosclerosis distribution and the effect of blood glucose level on operative mortality/morbidity in diabetic patients undergoing coronary artery bypass grafting surgery: a single center experience.

Tütün U, Ciçekçioğlu F, Budak B, Temürtürkan M, Parlar AI, Seren M, Ulus AT, Katircioğlu SF.

Anadolu Kardiyol Derg. 2007 Jun;7(2):158-63.

6.

Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients.

Kaireviciute D, Blann AD, Balakrishnan B, Lane DA, Patel JV, Uzdavinys G, Norkunas G, Kalinauskas G, Sirvydis V, Aidietis A, Lip GY.

Thromb Haemost. 2010 Jul;104(1):122-7. doi: 10.1160/TH09-12-0837. Epub 2010 May 10.

PMID:
20458440
7.

Amiodarone prophylaxis for atrial fibrillation of high-risk patients after coronary bypass grafting: a prospective, double-blinded, placebo-controlled, randomized study.

Budeus M, Hennersdorf M, Perings S, Röhlen S, Schnitzler S, Felix O, Reimert K, Feindt P, Gams E, Lehmann N, Wieneke H, Sack S, Erbel R, Perings C.

Eur Heart J. 2006 Jul;27(13):1584-91. Epub 2006 Jun 7.

PMID:
16760210
8.

Outcome of coronary artery bypass grafting in patients without major risk factors and patients with at least one major risk factor for coronary artery disease.

Nozari Y, Hashemlu A, Hatmi ZN, Sheikhvatan M, Iravani A, Bazdar A, Babakhan N, Ghasri NG.

Indian J Med Sci. 2007 Oct;61(10):547-54.

PMID:
17932445
9.

Predictive value of perioperative cardiac troponin I for adverse outcome in coronary artery bypass surgery.

Eigel P, van Ingen G, Wagenpfeil S.

Eur J Cardiothorac Surg. 2001 Sep;20(3):544-9.

PMID:
11509277
10.

Early troponin T and prediction of potentially correctable in-hospital complications after coronary artery bypass grafting surgery.

Göber V, Hohl A, Gahl B, Dick F, Eigenmann V, Carrel TP, Tevaearai HT.

PLoS One. 2013 Sep 6;8(9):e74241. doi: 10.1371/journal.pone.0074241. eCollection 2013.

11.
12.

Does preoperative atrial fibrillation increase the risk for mortality and morbidity after coronary artery bypass grafting?

Ad N, Barnett SD, Haan CK, O'Brien SM, Milford-Beland S, Speir AM.

J Thorac Cardiovasc Surg. 2009 Apr;137(4):901-6. doi: 10.1016/j.jtcvs.2008.09.050.

13.

Operative mortality in women and men undergoing coronary artery bypass grafting (from the California Coronary Artery Bypass Grafting Outcomes Reporting Program).

Bukkapatnam RN, Yeo KK, Li Z, Amsterdam EA.

Am J Cardiol. 2010 Feb 1;105(3):339-42. doi: 10.1016/j.amjcard.2009.09.035. Epub 2009 Dec 21.

PMID:
20102945
14.

Factors affecting post minimally invasive direct coronary artery bypass grafting incidence of myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting and mortality of cardiac origin.

Kofidis T, Gerd Paeschke H, Lichtenberg A, Emmert M, Woitek F, Didilis V, Haverich A, Klima U.

Interact Cardiovasc Thorac Surg. 2009 Jan;8(1):49-53. doi: 10.1510/icvts.2008.185280. Epub 2008 Sep 11.

15.

Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery.

Thielmann M, Neuhäuser M, Marr A, Jaeger BR, Wendt D, Schuetze B, Kamler M, Massoudy P, Erbel R, Jakob H.

J Thorac Cardiovasc Surg. 2007 Nov;134(5):1143-9.

16.

Propensity case-matched analysis of off-pump coronary artery bypass grafting in patients with atheromatous aortic disease.

Sharony R, Grossi EA, Saunders PC, Galloway AC, Applebaum R, Ribakove GH, Culliford AT, Kanchuger M, Kronzon I, Colvin SB.

J Thorac Cardiovasc Surg. 2004 Feb;127(2):406-13.

17.
18.

Effects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting.

Miceli A, Capoun R, Fino C, Narayan P, Bryan AJ, Angelini GD, Caputo M.

J Am Coll Cardiol. 2009 Nov 3;54(19):1778-84. doi: 10.1016/j.jacc.2009.07.008. Epub 2009 Aug 13.

19.

Changing volumes, risk profiles, and outcomes of coronary artery bypass grafting and percutaneous coronary interventions.

Aldea GS, Mokadam NA, Melford R Jr, Stewart D, Maynard C, Reisman M, Goss R.

Ann Thorac Surg. 2009 Jun;87(6):1828-38. doi: 10.1016/j.athoracsur.2009.03.067.

PMID:
19463603
20.

Angiographic coronary diffuseness and outcomes in dialysis patients undergoing coronary artery bypass grafting surgery.

Wong D, Thompson G, Buth K, Sullivan J, Ali I.

Eur J Cardiothorac Surg. 2003 Sep;24(3):388-92.

PMID:
12965309

Supplemental Content

Support Center